Navigation Links
UNIchip AV-VAR IP Premium from Protagen AG

ProductsUNIchip AV-VAR IP Premium from Protagen AG
Company Protagen AG
Item UNIchip AV-VAR IP Premium
Price 
Description UNIchip AV-400 contains 400 unique human proteins on a 1x3 inch nitrocellulose-coated glass slide. The proteins, all intracellular proteins (IP) according to Gene Ontology classification, are arrayed in quadruplicate for high-quality results. Additional control proteins and a specific chip layout guarantee high validity and reproducibility.

UNIchip protein microarrays are high-density protein biochips developed specifically for antibody characterization and validation. They enable early selection of the best antibody by providing quantitative data for sensitivity, dynamic range, and detection limit. Furthermore quantitative antibody fingerprints can be generated revealing the off-target activity of each antibody. This is achieved by printing customer antigen(s) onto the UNIchip and calculating relative signal intensities of the 400 human proteins to that of the target antigen.

Product is available in both a basic and a premium version.
In the basic version the individual antigen will be spotted by the customer, or the protein biochips can be used directly for off-target activity testing without any further processing.
In the premium version, Protagen also spots one or several customer specific antigens (proteins) onto the microarray allowing for quantitative analysis.

Info Protagen AG
Otto-Hahn-Str. 15
44227 Dortmund
Customer Service: +49 231 9742-6300
Fax Number: +49 231 9742-6301
Web Site: http://www.protagen.de
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. UNIchip AV-VAR EP Premium from Protagen AG
2. UNIchip AV-400 Premium from Protagen AG
3. Antibody validation service with UNIchip protein microarrays from Protagen AG
4. Protein Identification Service via MALDI MS/MS from Protagen AG
Mouse VEGF R1/Flt-1 Allophycocyanin MAb (Clone 141522) Keywords: Receptor Tyrosine Kinase, RTK, VEGFR1, VEGF Receptor 1 Protein Family: Receptor Tyrosine Kinases, VEGF/PDGF Family...
Recognizes Kir4.1. The epitope does not share homology with any other known proteins.,SPECIES REACTIVITIES: The antibody is also expected to work with mouse and human due to sequence homology. Oth...
Evi-1 Antibody Shipping Temperature: Cold Storage Temperature: -20C...
Profilin-1/2 (FL-140)...
Biology Products:
(Date:3/23/2017)... 2017 The report "Gesture Recognition and Touchless Sensing Market ... - Global Forecast to 2022", published by MarketsandMarkets, the market is expected to ... between 2017 and 2022. Continue Reading ... ... ...
(Date:3/20/2017)... At this year,s CeBIT Chancellor Dr. Angela ... The Chancellor came to the DERMALOG stand together with the Japanese Prime ... partner country. At the largest German biometrics company the two government leaders ... iris recognition as well as DERMALOG´s multi-biometrics system.   ... ...
(Date:3/9/2017)... FRANCISCO and MOUNTAIN VIEW, Calif. ... , "Eating Well Made Simple," and 23andMe , ... help guide better food choices.  Zipongo can now provide ... their food preferences, health goals and biometrics, but also ... certain food choices. Zipongo,s personalized food decision ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... March 23, 2017  SeraCare Life Sciences, ... in vitro diagnostics manufacturers and clinical laboratories, ... first multiplexed Inherited Cancer reference material ... by next-generation sequencing (NGS). The Seraseq™ Inherited Cancer ... input from industry experts to validate the ...
(Date:3/23/2017)... YORK , March 23, 2017 ... ... of death, putting significant strain on health care systems, in ... cancer diagnoses rises, so too does the development of innovative ... minimum side effects. Among the many types of cancer treatments, ...
(Date:3/22/2017)... Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), today announced a ... Biobank and GSK to generate genetic sequence data from the ... will enable researchers to gain valuable insights to support advances ... of serious and life threatening diseases. ... Genetic evidence has revolutionized ...
(Date:3/22/2017)... 22, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... www.oramed.com ), a clinical-stage pharmaceutical company ... systems, announced today that Dr. Miriam Kidron ... presentation titled, "Oral Insulin for Diabetes Treatment: Bypassing ... Institute,s Oligonucleotide and Peptide Therapeutics (OPT) Boston Conference in ...
Breaking Biology Technology: